Global Neurotoxin Market by Type; by Applications; by End User; by Region (North America, Europe, Asia-pacific, Latin America, Middle East Africa): Global Forecasts 2021 To 2027

The Global Neurotoxin Market was valued at USD 4.9 Bn in 2020 and is expected to reach USD 8.2 Bn by 2027, with a growing CAGR of 7.7% during the forecast period.

Global Neurotoxin Market Definition

Neurotoxin is the substance which is obtained from plants or animals (exogenous) that causes damage to the functioning of the peripheral or central nervous system. This toxin adversely affects the functions and development of nervous tissue. Common examples of neurotoxins include snake venom, pesticides, ethanol, nitric oxide, botulinum toxin, tetanus toxin, lead or tetrodotoxin. However, neurotoxins are important in cell communications in the nervous system, which depends on the dosage. Neurotoxins hold huge applications in therapeutics and aesthetic procedures such as botulinum is widely used in diminishing or smoothing lines of the skin when given in specific dose.

Neurotoxin Market

Global Neurotoxin Market Dynamics

The driving factors influencing the global neurotoxin market include rising demand for the minimal invasive to non-invasive cosmetic procedures and growing awareness regarding use of neurotoxins in the aesthetic methodologies. For instance, Botox®, a medically clarified Botulinum neurotoxin which is obtained from bacteria is being used alone or in the combination of other products to provide rejuvenation to the face by minimal invasive procedure. Botox® injections helps to reduce muscle contractions which lead to the decrease in wrinkles and lines on the face. Other brands of botulinum toxin include Neucieva, Dysport®, and Xeomin® are largely used in the treatment of mental disorders such as Alzheimers, dementia and in various aesthetic procedures. Moreover, increase in disposable income and growing procedure affordability is expected to fuel the growth of neurotoxin demand in the market.

Growing product launch and investments in enhancing the medical applications of the neurotoxin is expected to propel the growth of the neurotoxin demand in the market during the forecast period. Furthermore, rising awareness about available neurotoxin products for aesthetic procedures is expected to generate high revenue in the neurotoxin market during the forecast period. For instance, in June 2021, Allergan PLC (Ireland) initiated a campaign called ‘See Yourself’ that would enlighten people about the advantages of Botox cosmetic treatments. This campaign promotes the success stories of real Botox cosmetic patients in idea of motivating large number of populations to apply for this treatment. Botox® Cosmetics is the first ever brand that would focus on the unique successful journey of their consumers, and aim to create transparency, emotional connect with all those people who tend to choose aesthetic treatment for themselves. This would develop brand loyalty among customers and help the company to maintain their position in the neurotoxin demand in the market.

On the contrary, high cost of aesthetic procedures and potential side effects associated with Botox therapies are expected to hinder the growth of the neurotoxin demand in the market during the forecast period. Side effects such as difficulty in urination, headache, back pain, sore throat, fever, and allergenic reactions with Botox ingredients are expected to decrease the adoption level of the population which might affect the growth of neurotoxin demand in the market during the forecast period.

Global Neurotoxin Market Segmentation:

By Type

  • Botulinum Toxin A
  • Botulinum Toxin B

By Applications


  • Therapeutics
    • Overactive Bladder
    • Chronic Migraine
    • Spasticity
    • Cervical Dystonia
    • Blepharospasm
    • Others
  • Aesthetics

By End User

  • Hospitals & Clinics
  • Dermatology clinics & Specialty

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Company Profiles and Competitive Intelligence

The key players operating in the neurotoxin market are:

  • Allergan PLC.
  • U.S. WorldMeds.
  • Hugh Source (International) Ltd.
  • Galderma laboratories.
  • Revance Therapeutics, Inc.
  • Ipsen Pharma.
  • Merz Pharma GmbH & Co. KGaA.
  • Daewoong Pharmaceuticals Co.,Ltd
  • Pfizer
  • Lanzhou Institute of Biological Products Co. Ltd
  • Medytox Inc.
  • Vensica Therapeutics
  • Others
  • Teijin Pharma Limited
  • Aquavit Holdings LLC
  • Huons Bio Pharma
  • UroGen Pharma

Based on applications, aesthetic segment is expected to hold largest market share during the forecast period due to increasing use of botulinum toxins in aesthetic procedures

Based on applications, neurotoxin market is broadly segmented into therapeutic and aesthetic segments. Therapeutic is further sub-segmented into overactive bladder, cervical dystonia, spasticity, chronic migraine, and blepharospasm. Aesthetic segment held largest market share in 2020 due to rise in number of aesthetic procedures such as chemical peels, cosmetic dermatology treatments, dermal filles, and microdermabrasion. For instance, according to the American Society of Plastic Surgeon 2020, more than ~13 Mn cosmetic minimal invasive procedures were performed in 2020 to enhance the body features of the population. Moreover, aesthetic segment is expected to hold largest market share during the forecast period due to growing number of product launch and rising awareness regarding botulinum toxin products and its applications. For instance, in January 2021, Merz Aesthetics (Germany) and Candela Corporation (US) joined hands for the expansion of their product portfolio of skin care products, devices and injectables. This collaboration is expected to enhance their offerings to meet full-spectrum aesthetic care to the end customer. This collaboration is expected to provide better customer access to the innovative aesthetic products across the globe. Such rising invention and research in aesthetic procedures is expected to boost the neurotoxin demand in the market during the forecast period.

Based on end user, hospital & clinics segment is expected to hold largest share in market during the forecast period due to rising number of cosmetic clinics and increasing hospital admissions for aesthetic therapy  

Based on end user, medical aesthetic market is segmented into hospital & clinics, beauty centers, and home care. Hospitals & clinic is expected to contribute highest to the market during forecast period owing to increase in number of admissions for plastic surgeries, adaption of spas & clinic and presence of medical infrastructure at one place. Moreover, technological advances in medical devices and availability of trained staff & professionals drives the growth of the neurotoxin market during the forecast period.

Based on region, North America is expected to dominate the market during the forecast period due to increase in disposable income of the population

Based on region, North America held the largest share in the market in 2020 due to increased attention of female population towards beautification that derives the demand for Botox in the North America. According to the study of American Society of Plastic Surgeons, non-invasive cosmetic procedure proves to be the most popular among female population, more likely, ~5 Mn procedure were performed in 2020. Growing inclination towards. Moreover, growing inclination towards non-invasive cosmetic procedure is expected to fuel the growth of neurotoxin market during the forecast period. Furthermore, increasing ageing population and growing healthcare infrastructure is expected to boost the neurotoxin market during the forecast period. For instance, according to American Society of Plastic Surgeons, majority of Botox users fall in the age group of 45-60 years. About 45% of total procedures are performed by this age group. Such growing awareness and availability of products for enhancing external appearance are expected to pull the growth of the neurotoxin demand in the market during the forecast period.

The report also provides in-depth analysis of neurotoxin market dynamics such as drivers, restraints, opportunities, and challenges


  • Growing inclination towards western lifestyle
  • Rising use of botulinum toxin as anti-aging treatment
  • Growing awareness regarding use of neurotoxin for beautification
  • Rise in disposable income
  • Increasing demand for minimal invasive cosmetic procedure


  • Inflated cost of neurotoxin treatment
  • Harmful side effects caused by use of toxins in the body


  • Emerging large number of start-up companies
  • Growing product launch in the market


  • Ethical and social issues related to cosmetic treatments
  • Growing incidence of elective aesthetic treatments in youngsters

COVID-19 Impact on the Neurotoxin Market Analysis

Covid-19 has negatively impacted the growth of neurotoxin demand in the market across the globe. Sudden drop in the sales of botulinum toxin was reported due to the pandemic in 2020 as there was decline in demand and supply of neurotoxin related products. During covid-19 outbreak, first preference was given the health monitoring of covid-19 patients and other surgeries & consulting were kept on hold. Many hospitals and clinics across the globe restructured their healthcare system and facilities towards covid-19 crisis. However, the neurotoxin demand in the market is expected to flourish in coming years after normalization of the situation across the world during the forecast period.

 The report also provides an in-depth analysis of key trends in neurotoxin market

Sr. No. Trends Impact
1 Rising application of neurotoxins in chin implants as fillers for volume effect Positive
2 Growing developments in use of fillers in various areas by altering their biological composition is expected to keep trend evolving in creation of new filler that is reversible, non-immunogenic, and biodegradable Positive

The report also provides an in-depth analysis of recent news developments and investments

  • In April 2021, Aquavit Holdings LLC (Brazil) along with Huons Bio Pharma (South Korea) received the exclusive license agreement to design and market a botulinum toxin (DTX-021) in US and Canada. Aquavit plans to the initiate the IND filing registration process with FDA. Botulinum toxin (DTX-021) is expected to enhance and show higher equivalency on periorbital rhytids as compared to botulinum toxin A in controlled phase III clinical trial. The commercialization of DTX-021 is expected to enhance the business and increase the presence of Aquavit in the US and Canada market.
  • In June 2020, Teijin Pharma Limited (Japan) and Merz Pharma GmbH & Co. KGaA (Germany) jointly received approval for marketing Merz’s Xeomin® as treatment for intramuscular injection with 50, 100 or 200 units for upper limb spasticity. Xeomin® is developed by Merz Pharma GmbH & Co. KGaA composing a highly purified neurotoxin. The marketing of this product is expected to provide better healthcare outcome to the patients and physicians across the world.

The unique insights provided by this report also includes the following:

  • In-depth Value Chain Analysis
  • Opportunity Mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market Trends
  • Covid-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impacts on Neurotoxin Market
  • Competitive Landscape

Frequently Asked Questions (FAQs)

The global neurotoxin market was valued at USD 4.9 Bn in 2020 and is anticipated to reach USD 8.2 Bn by 2027.

The global neurotoxin market is estimated to grow at a compound annual growth rate (CAGR) of 7.7% during forecast period.

In the base year 2020, North America accounted for the highest share in the market.

Stringent government policies for therapy approvals restraint the growth of global neurotoxin market.

As per expert opinions, increase in number therapeutic applications of botulinum toxin, growing inclination towards cosmetic surgeries of female population, rising awareness related to the minimal invasive number of R&D and clinical trials for novel cancer therapy development will drive the growth of global neurotoxin market.

The global neurotoxin market players include Allergan PLC., U.S. WorldMeds., Hugh Source (International) Ltd., Galderma laboratories., Revance Therapeutics, Inc., Ipsen Pharma., Merz Pharma GmbH & Co. KGaA., Daewoong Pharmaceuticals Co.,Ltd, Pfizer, Lanzhou Institute of Biological Products Co. Ltd, and Medytox Inc.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1.  Introduction
    1. Product Outline
    2. What is Neurotoxin?
    3. Analysis of Neurotoxin Market
    4. Covid -19 Impact
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
    6. Technology Overview
  2. Regulatory Landscape for Neurotoxin Market
    1. Regulations and Standards
  3. Neurotoxin Market by Type
    1. Botulinum Toxin A
    2. Botulinum Toxin B
  4. Neurotoxin Market by Applications
    1. Therapeutics
      1. Overactive Bladder
      2. Chronic Migraine
      3. Spasticity
      4. Cervical Dystonia
      5. Blepharospasm
      6. Others
    2. Aesthetics
  5. Neurotoxin Market by End User
    1. Dermatology Clinics & Specialty
    2. Hospitals & Clinics
  6. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France 
      4. Spain
      5. Netherlands
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest Of Asia Pacific
    4. Latin America
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    5. Middle East Africa (MEA)
      1. GCC
      2. Rest of MEA
  7. Key Strategic Insights
    1. New Applications
    2. Emerging Technologies
    3. Opportunity Mapping
    4. Critical Success Factors
    5. Environmental Impact and Sustainability Issues
    6. Customer Preferences
  8. Key Market Trends / Recent Developments
  9. Competitive Scenario
    1. Mergers and Acquisitions
    2. Investments
    3. Joint Ventures
    4. New Product launches
    5. Strength of product portfolio
    6. Ranking of Key Players
    7. Presence of players by Geographies
  10. Key global players
    1. Allergan PLC.
    2. U.S. WorldMeds.
    3. Hugh Source (International) Ltd.
    4. Galderma laboratories.
    5. Revance Therapeutics, Inc.
    6. Ipsen Pharma.
    7. Merz Pharma GmbH & Co. KGaA.
    8. Daewoong Pharmaceuticals Co.,Ltd
    9. Pfizer
    10. Lanzhou Institute of Biological Products Co. Ltd
    11. Medytox Inc.
    12. Others

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization